Insurances & Business

Cephalon shares fall ahead of FDA panel on pain drug Fentora (AP)

Business | Sources: Yahoo

Similar/Related/News:

• Merck shares fall on FDA drug rejection, Abbott shares rise (AP)
Merck & Co. shares fell Tuesday after the Food and Drug Administration rejected the drugmaker's cholesterol drug Cordaptive, marking the company's sec...
• Tokyo shares fall ahead of Fed decision (AP)
Japanese shares fell Wednesday as investors sold commodity stocks, although investors were cautious ahead of an announcement by the U.S. Federal Reser...
• Novartis shares jump as cancer drug shows promise (AP)
Shares of drug developer Novartis AG jumped Monday after the company said its kidney cancer drug candidate delayed tumor growth twice as long as place...
• Discovery shares plunge on delay for key drug candidate (AP)
Discovery Laboratories Inc. shares plunged Friday after its key drug candidate faced another regulatory delay with the Food and Drug Administration, f...
• Costs Of Back Pain Influenced By Socio-Demographic Factors
It is well-known that back pain belongs to the most frequent health problems in the industrial nations and, it is also well-known that it is the cause...
• Human Genome Sciences shares fall on drug candidate swap (AP)
Shares of Human Genome Sciences fell Thursday after the biotechnology company bought back the rights to its cancer treatments, a move one analyst said...
• Out of the Gate: QLT climbs after RBC upgrades (AP)
Shares of QLT Inc. rose Thursday after an RBC Capital Markets analyst upgraded the drug maker, saying it is underpriced given a recent divestiture and...
• US home prices fall at record pace
An index of house prices has fallen 14.1 per cent for the first quarter compared with the same period last year, a trend that could prolong the econom...